Validation of cyclin D1/CDK4 as an anticancer drug target in MCF-7 breast cancer cells: Effect of regulated overexpression of cyclin D1 and siRNA-mediated inhibition of endogenous cyclin D1 and CDK4 expression

By Grillo Mary   Bott Matthew   Khandke Neha   McGinnis John   Miranda Miriam   Meyyappan Muthupalaniappan   Rosfjord Edward   Rabindran Sridhar  

Breast Cancer Research and Treatment, Vol. 95, Iss. 2, 2006-01 ,pp. : 185-194

Springer Publishing Company

Access to resources Recommend Favorite

Polymorphisms in ESR1 and FLJ43663 are associated with breast cancer risk in the Han population

By Xia Peng   Jin Tianbo   Geng Tingting   Sun Ting   Li Xiaolan   Dang Chengxue   Kang Longli   Chen Chao   Sun Jiying  

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2187-2190

Springer Publishing Company

Access to resources Recommend Favorite

Combined effect of papuamine and doxorubicin in human breast cancer MCF7 cells

By                

Oncology Letters, Vol. 8, Iss. 2, 2014-01 ,pp. : 547-550

Spandidos Publications

Access to resources Recommend Favorite

Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer

By Adegoke Olufemi   Shu Xiao   Gao Yu-Tang   Cai Qiuyin   Breyer Joan   Smith Jeffrey   Zheng Wei  

Breast Cancer Research and Treatment, Vol. 85, Iss. 3, 2004-06 ,pp. : 239-245

Springer Publishing Company

Access to resources Recommend Favorite

Estrogen Receptor Beta (ESR2) Polymorphisms in Familial and Sporadic Breast Cancer

By Maguire Paula  

Breast Cancer Research and Treatment, Vol. 94, Iss. 2, 2005-11 ,pp. : 145-152

Springer Publishing Company

Access to resources Recommend Favorite